4//SEC Filing
Zoghbi Huda Y 4
Accession 0001708138-21-000081
CIK 0000872589other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:03 PM ET
Size
13.0 KB
Accession
0001708138-21-000081
Insider Transaction Report
Form 4
Zoghbi Huda Y
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-13$391.92/sh+2$784→ 893 total - Exercise/Conversion
Common Stock
2021-09-14$391.92/sh+998$391,136→ 1,889 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-09-13−2→ 5,115 totalExercise: $391.92Exp: 2026-09-09→ Common Stock (2 underlying) - Sale
Common Stock
2021-09-13$651.10/sh−2$1,302→ 891 total - Sale
Common Stock
2021-09-14$650.00/sh−998$648,700→ 891 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-09-14−998→ 4,117 totalExercise: $391.92Exp: 2026-09-09→ Common Stock (998 underlying)
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001681643
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:03 PM ET
- Size
- 13.0 KB